What is the recommended starting dose, titration schedule, monitoring parameters, and contraindications for spironolactone (Aldactone) in an adult with cirrhosis and ascites?

Spironolactone (Aldactone) for Cirrhotic Ascites

Start spironolactone at 100 mg once daily in the morning, combined with furosemide 40 mg daily, for adults with moderate-to-severe cirrhotic ascites. 1, 2, 3

Starting Dose

• Initial combination therapy: Spironolactone 100 mg + furosemide 40 mg once daily in the morning is the preferred first-line regimen for moderate-to-severe ascites (Grade 2-3). 1, 2, 3

• Mild ascites (Grade 1): For first-episode minimal ascites in outpatients, spironolactone monotherapy at 50-100 mg daily may be started, though most patients will eventually require addition of furosemide. 1, 3

• Always use oral formulations: Intravenous administration causes acute kidney injury due to sudden fluid loss and should never be used. 1, 3

• Hospitalization requirement: The FDA label mandates initiating spironolactone in the hospital for patients with cirrhosis and ascites due to risk of sudden electrolyte shifts precipitating hepatic encephalopathy. 4

Titration Schedule

• Increase every 3-5 days if weight loss or natriuresis is inadequate, maintaining the 100:40 ratio of spironolactone to furosemide. 1, 3

• Maximum doses: Spironolactone 400 mg/day and furosemide 160 mg/day. 1, 3

• Target weight loss: 0.5 kg/day without peripheral edema; no strict limit when edema is present, but monitor carefully. 1, 2, 3

• Spironolactone requires 3-4 days to reach stable concentration due to its long half-life, so dose adjustments should not be made more frequently. 1

Monitoring Parameters

First Week

• Check within 1 week: Serum potassium, creatinine, sodium, and BUN. 3, 4
• Monitor blood pressure, body weight, and vital signs at each visit. 3

Weeks 2-4

• Repeat electrolyte panel every 5-7 days until values stabilize. 3

Months 1-3

• Assess renal function and electrolytes at 1,2, and 3 months. 3

After 3 Months

• If stable, continue monitoring every 3-6 months. 3

Natriuresis Assessment

• 24-hour urine sodium >78 mmol/day (on 88 mmol/day dietary sodium) indicates adequate response. 3
• Spot urine Na/K ratio >1 correlates with sufficient sodium excretion; if ≤1, increase diuretic doses. 3

Dose Adjustments for Electrolyte Abnormalities

Hyperkalemia

• K+ ≥6.0 mmol/L: Stop spironolactone immediately. 1, 3, 4
• K+ 5.5-5.9 mmol/L: Reduce spironolactone dose by 50%. 3
• Patients with renal impairment require lower spironolactone doses from the start. 3, 4

Hypokalemia

• Temporarily hold or reduce furosemide; do not add potassium supplements. 1, 3

Severe Hyponatremia

• Serum Na <120-125 mmol/L: Reduce or discontinue diuretics despite fluid restriction. 1, 3

Acute Kidney Injury

• Creatinine increase ≥0.3 mg/dL within 48 hours or ≥50% rise or absolute value >2.0 mg/dL: Suspend or reduce diuretics. 1, 5, 3

Contraindications and Critical Safety Thresholds

Absolute Contraindications

• Hyperkalemia (K+ >6.0 mmol/L). 4
• Acute kidney injury. 1, 3
• Severe hyponatremia (<120 mmol/L). 1, 5, 3

Relative Contraindications/Cautions

• Overt hepatic encephalopathy: Reduce or stop diuretics. 1
• Severe muscle spasms: Reduce or stop diuretics. 1
• Renal impairment: Higher risk of hyperkalemia; monitor potassium closely. 4
• Elderly patients: More likely to have decreased renal function; monitor closely. 4

Common Pitfalls and How to Avoid Them

Gynecomastia

• Occurs in dose-dependent manner, onset 1-2 months to >1 year, affects ~9% of males at mean dose 26 mg/day. 4
• If tender gynecomastia develops: Replace spironolactone with amiloride 10-40 mg/day (1/10 the spironolactone dose), though amiloride is less potent. 1, 3

Drug Interactions

• Avoid NSAIDs: They blunt natriuretic response, increase hyperkalemia risk, and can convert diuretic-sensitive patients to refractory. 1, 5, 3
• Discontinue ACE inhibitors and ARBs: These increase hyperkalemia risk and reduce glomerular filtration. 1, 4
• Never combine two renin-angiotensin system blockers (ACE inhibitor + ARB). 3

Refractory Ascites Definition

• Failure to respond after at least 1 week of maximum doses (spironolactone 400 mg + furosemide 160 mg) on salt-restricted diet (<5 g/day). 1
• Mean weight loss <800 g over 4 days with urinary sodium output less than intake. 1
• When refractory ascites develops, consider discontinuing diuretics if urinary sodium excretion is <30 mmol/day and proceed to large-volume paracentesis. 1

Supportive Measures

• Sodium restriction: 2 g/day (88 mmol/day) or ≤5 g salt/day is essential. 1, 2
• Protein supplementation: 1.2-1.5 g/kg/day to prevent malnutrition. 1, 2
• Fluid restriction: Not necessary unless serum sodium is <120-125 mmol/L. 1, 5, 1
• Dietitian referral: Should be made to support sodium restriction and prevent caloric/protein deficiency. 2